Literature DB >> 18819094

Sibling history of asthma is a risk factor for pain in children with sickle cell anemia.

Joshua J Field1, Eric A Macklin, Yan Yan, Robert C Strunk, Michael R DeBaun.   

Abstract

The basis of the association between asthma and an increased rate of pain among children with sickle cell anemia (SCA) is unclear. To provide evidence for a familial contribution to this observation, we tested the hypothesis that a family history of asthma is associated with an increased pain rate. Using data from the Cooperative Study for Sickle Cell Disease (CSSCD), we identified 211 children with SCA with asthma history of the parents and siblings. A sibling history of asthma was associated with a greater rate of pain (mean rate ratio = 2.48, 95% CI = 1.6-4.0; P < 0.001) when compared with children without a sibling history of asthma. Parental history of asthma was not associated an increase rate of pain (mean ratio = 1.51, 95% CI= 0.92-2.62; P = 0.12). Further studies are needed to examine genetic and/or environmental risks for asthma as potential contributors to pain in children with SCA. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18819094      PMCID: PMC2590666          DOI: 10.1002/ajh.21275

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  13 in total

Review 1.  Sickle cell disease: a multigenic perspective of a single gene disorder.

Authors:  Abdullah Kutlar
Journal:  Hematology       Date:  2005       Impact factor: 2.269

Review 2.  Gene-environmental interaction in asthma.

Authors:  Ian A Yang; Santiyagu Savarimuthu; Samuel T Kim; John W Holloway; Scott C Bell; Kwun M Fong
Journal:  Curr Opin Allergy Clin Immunol       Date:  2007-02

3.  Major gene effect and additive familial pattern of inheritance of asthma exist among families of probands with sickle cell anemia and asthma.

Authors:  Keydra L Phillips; Ping An; Jessica H Boyd; Robert C Strunk; James F Casella; Bruce A Barton; Michael R DeBaun
Journal:  Am J Hum Biol       Date:  2008 Mar-Apr       Impact factor: 1.937

4.  The cooperative study of sickle cell disease: review of study design and objectives.

Authors:  M Gaston; W F Rosse
Journal:  Am J Pediatr Hematol Oncol       Date:  1982

5.  Acute chest syndrome in sickle cell disease: clinical presentation and course. Cooperative Study of Sickle Cell Disease.

Authors:  E P Vichinsky; L A Styles; L H Colangelo; E C Wright; O Castro; B Nickerson
Journal:  Blood       Date:  1997-03-01       Impact factor: 22.113

6.  Temporal relationship of asthma to acute chest syndrome in sickle cell disease.

Authors:  Karl P Sylvester; Richard A Patey; Simon Broughton; Gerrard F Rafferty; David Rees; Swee Lay Thein; Anne Greenough
Journal:  Pediatr Pulmonol       Date:  2007-02

7.  Family history and the risk of early-onset persistent, early-onset transient, and late-onset asthma.

Authors:  S J London; W James Gauderman; E Avol; E B Rappaport; J M Peters
Journal:  Epidemiology       Date:  2001-09       Impact factor: 4.822

8.  Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms.

Authors:  Laurie Duckworth; Lewis Hsu; Hua Feng; Jianwei Wang; James E Sylvester; Niranjan Kissoon; Eric Sandler; John J Lima
Journal:  Pediatr Pulmonol       Date:  2007-04

9.  Asthma and acute chest in sickle-cell disease.

Authors:  Jessica H Boyd; Asif Moinuddin; Robert C Strunk; Michael R DeBaun
Journal:  Pediatr Pulmonol       Date:  2004-09

10.  The acute chest syndrome in sickle cell disease: incidence and risk factors. The Cooperative Study of Sickle Cell Disease.

Authors:  O Castro; D J Brambilla; B Thorington; C A Reindorf; R B Scott; P Gillette; J C Vera; P S Levy
Journal:  Blood       Date:  1994-07-15       Impact factor: 22.113

View more
  8 in total

Review 1.  Asthma morbidity and treatment in children with sickle cell disease.

Authors:  Samuel O Anim; Robert C Strunk; Michael R DeBaun
Journal:  Expert Rev Respir Med       Date:  2011-10       Impact factor: 3.772

2.  End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.

Authors:  Ann T Farrell; Julie Panepinto; Ankit A Desai; Adetola A Kassim; Jeffrey Lebensburger; Mark C Walters; Daniel E Bauer; Rae M Blaylark; Donna M DiMichele; Mark T Gladwin; Nancy S Green; Kathryn Hassell; Gregory J Kato; Elizabeth S Klings; Donald B Kohn; Lakshmanan Krishnamurti; Jane Little; Julie Makani; Punam Malik; Patrick T McGann; Caterina Minniti; Claudia R Morris; Isaac Odame; Patricia Ann Oneal; Rosanna Setse; Poornima Sharma; Shalini Shenoy
Journal:  Blood Adv       Date:  2019-12-10

Review 3.  Differences in the clinical and genotypic presentation of sickle cell disease around the world.

Authors:  Santosh L Saraf; Robert E Molokie; Mehdi Nouraie; Craig A Sable; Lori Luchtman-Jones; Gregory J Ensing; Andrew D Campbell; Sohail R Rana; Xiao M Niu; Roberto F Machado; Mark T Gladwin; Victor R Gordeuk
Journal:  Paediatr Respir Rev       Date:  2013-11-15       Impact factor: 2.726

Review 4.  Wheezing in children with sickle cell disease.

Authors:  Jeffrey A Glassberg; Robert Strunk; Michael R DeBaun
Journal:  Curr Opin Pediatr       Date:  2014-02       Impact factor: 2.856

5.  Asthma in sickle cell disease: implications for treatment.

Authors:  Kathryn Blake; John Lima
Journal:  Anemia       Date:  2011-03-03

Review 6.  A scoping review on the study of siblings in pediatric pain.

Authors:  Meghan G Schinkel; Christine T Chambers; Jill A Hayden; Abbie Jordan; Justine Dol; Kristen S Higgins
Journal:  Can J Pain       Date:  2017-12-05

Review 7.  Asthma management in sickle cell disease.

Authors:  Esteban Gomez; Claudia R Morris
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

Review 8.  Sickle cell disease: wheeze or asthma?

Authors:  Robyn T Cohen; Elizabeth S Klings; Robert C Strunk
Journal:  Asthma Res Pract       Date:  2015-12-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.